May 18, 2022
Japan’s key health ministry panel will discuss whether to put forward a host of medicines for approval at its upcoming meeting on May 30 including Taiho Pharmaceutical’s oral heat shock protein (HSP) 90 inhibitor pimitespib. The Pharmaceutical Affairs and Food...read more